Phezam is a combination prescription medicine containing Piracetam 400 mg and Cinnarizine 25 mg per capsule. The formulation combines the nootropic properties of piracetam with the vascular effects of cinnarizine to support cerebral blood flow, brain metabolism, and cognitive performance.
Phezam is widely used in neurological practice as part of the management of chronic cerebrovascular disorders, dizziness, memory impairment, and other neurological conditions.
Phezam may be prescribed for:
Piracetam supports neuronal metabolism, enhances communication between brain cells, and contributes to cognitive function.
Cinnarizine improves cerebral microcirculation, reduces vascular spasm, and decreases vestibular sensitivity.
Together, the two ingredients help:
Use Phezam only as directed by a healthcare professional.
The dosage and duration of treatment depend on the patient's condition and physician's recommendations.
Possible adverse reactions include:
Consult your physician if severe or persistent symptoms occur.
Do not use in patients with:
Store according to the manufacturer's instructions in a dry place away from direct sunlight and out of the reach of children.
Phezam is prescribed to support cerebral circulation, cognitive function, memory, and vestibular disorders.
Each capsule contains Piracetam 400 mg and Cinnarizine 25 mg.
Yes. It combines a nootropic agent with a cerebral circulation modulator.
Yes. Cinnarizine is commonly used to reduce vestibular symptoms and vertigo.
In selected cases, physicians may recommend it for motion sickness prevention.
Treatment duration should always be determined by a healthcare professional.
Ask a question or inquire about delivery to your country
